WASHINGTON, D.C. – The Health subcommittee for the U.S. House Committee on Energy and Commerce on Wednesday held a three-plus hours-long hearing on the topic of “Cannabis Policies for the New Decade,” which examined legislative proposals that would allow significant federal policy reform, if passed. Wednesday’s hearing focused mainly on cannabis research. In his opening […]
Controlled Substances Act
Anna G. Eshoo, Barbara Lee, Bloomberg Law, cannabis news, cannabis reform bills, Controlled Substances Act, CSA, DEA, Department of Veterans Affairs, Drug Enforcement Administration, Earl Blumenauer, FDA, Featured Story, federal marijuana laws, Food and Drug Administration, H.R. 1151, H.R. 171, H.R. 2843, H.R. 3797, H.R. 3884, H.R. 601, Hakeem S. Jeffries, House Energy and Commerce Health Subcommittee, Jerrold Nadler, Legitimate Use of Medicinal Marihuana Act, Marijuana Freedom and Opportunity Act, Marijuana Opportunity Reinvestment and Expungement Act of 2019, marijuana research, Matt Gaetz, Medical Cannabis Research Act of 2019, Medical Marijuana Research Act of 2019, Morgan Griffith, National Institute on Drug Abuse, National Institutes of Health, NIH, VA, Veterans Medical Marijuana Safe Harbor Act
WASHINGTON, D.C. – 2020 could be shaping up to be a major turning point for federal cannabis law. Multiple cannabis reform bills will be debated by the congressional committee of House Energy and Commerce’s subcommittee on Health this Wednesday. According to a memo about the meeting, a total of six bills will be included in […]
cannabis reform, Congress, Controlled Substances Act, donald trump, Erik Altieri, Featured Story, Georgia, House, HR876, industry news, Legal & Politics, legalization, norml, Politics, Prohibition, Senate, u s senate, U.S. House of Representatives
Momentum for several changes to federal cannabis law has stalled in the U.S. Senate. In June, the House included in an appropriations bill a measure that would protect all cannabis programs enacted by state and indigenous tribes from federal interference. The Senate has decided to drop the provision. Instead, medicinal cannabis protections in place since […]
Aaron Smith, act, Bureau of Labor Statistics, Cannabis Justice Office, cannabis news, Congress, Controlled Substances Act, Erik Altieri, expungement, Featured Story, Federal, H.R. 3884, history, House Judiciary Committee, House of Representatives, Jerrold Nadler, Legal & Politics, legalization, Marijuana, Marijuana Opportunity Reinvestment and Expungement Act, MORE, MORE Act of 2019, National Cannabis Industry Association, ncia, norml, Prohibition, Veterans' Affairs, vote
WASHINGTON, D.C. – In what may be a historic turn in federal cannabis politics, the House Judiciary Committee today approved a bill to federally decriminalize cannabis by removing it from the Controlled Substances Act. By a count of 24-10, the committee voted in favor of the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H.R. 3884. […]
Thanks to controversial civil asset forfeiture laws, police can often permanently seize a suspect’s vehicle if they are caught using it to transport marijuana.
The demand for plant-based alternatives to pharmaceuticals and Western medicine has never been greater. Yet, while support for plant medicine increases, our understanding of its potential medical benefits and risks remains inadequate. As more patients seek alternative solutions for chronic pain, post-traumatic stress disorder, anxiety, and other conditions, there remains a lack of standardization surrounding […]
Aaron Smith, Alcohol and Tobacco Tax and Trade Bureau, Congress, Controlled Substances Act, Cova Software, DEA, Drug Enforcement Administration, FDA, Featured Story, federal government, Food and Drug Administration, greenlane, Ionic, Ionic Brands, Legal & Politics, legalization, ncia, sc labs, TTB, U.S. House of Representatives, Vaping, Vaping Crisis, Vaping Death, vaping illness
WASHINGTON, D.C. – The National Cannabis Industry Association (NCIA) today delivered a letter to the U.S. House of Representatives urging Congress to take federal action in order to mitigate the nation’s ongoing epidemic of vaping-related illness. The letter, signed by approximately 800 individuals, included signatories from dozens of cannabis businesses such as SC Labs, Greenlane, […]
cannabis decriminalization, Controlled Substances Act, Featured Story, federal regulation, Florida, Greg Steube, House Committee on the Judiciary, Legal & Politics, legislation, Marijuana 1-to-3 Act of 2019, regulation, reschedule, Research, Schedule I, Schedule III, U.S. Attorney General
WASHINGTON, D.C. – Congressman Greg Steube (R-Fla.) on Thursday introduced the Marijuana 1-to-3 Act of 2019. If passed, the act would reschedule cannabis from a Schedule I controlled substance to a Schedule III controlled substance, loosening current restrictions on cannabis research. “As marijuana is legalized for medical and recreational use across the United States, it […]
2016 Election, 2020 election, Bernie Sanders, Controlled Substances Act, criminal justice reform, Democratic Primaries, Executive action, Executive orders, Featured Story, Joe Rogan, Joe Rogan Experience, Legal & Politics, legalization, marijuana jobs, Mass Incarceration, podcast, President Donald Trump, Vice President Joe Biden, war on drugs
Cannabis legalization is backed by most of the Democratic Party’s candidates vying for the party’s nomination, with the notable exception of former Vice President Joe Biden. While a pro-cannabis stance is becoming commonplace for democrats, it was not always the case, even as recently as the last presidential election. Bernie Sanders’ bold 2016 campaign helped […]
Sanders, a longtime legalization advocate, said that as president, he would bypass partisan bickering in Congress and legalize cannabis through an executive order.
The post Bernie Says He’d Legalize Cannabis Through Executive Order appeared first on Leafly.